powered by centersite dot net
Childhood Mental Disorders and Illnesses
Resources
Basic Information
Introduction to Disorders of ChildhoodIntellectual DisabilitiesMotor Skills DisordersLearning DisordersCommunication DisordersAutism and Pervasive Developmental DisordersADHD and Disruptive Behavior DisordersFeeding and Elimination DisordersAnxiety DisordersReactive Attachment DisorderStereotypic Movement DisorderTic DisordersInfancy, Childhood or Adolescence, Not Otherwise Specified
Latest NewsQuestions and AnswersVideosLinksBook Reviews
Related Topics

Autism
Child & Adolescent Development: Overview
Parenting
Child Development & Parenting: Infants (0-2)
Child Development & Parenting: Early (3-7)
Child Development & Parenting: Middle (8-11)

ADHD Rx Associated With a Lower Risk for Alcohol, Drug Abuse


HealthDay News
Updated: Jul 25th 2017

new article illustration

TUESDAY, July 25, 2017 (HealthDay News) -- Teens and adults with attention-deficit/hyperactivity disorder (ADHD) may have a lower risk of developing an alcohol or drug problem if they take medications to treat their ADHD, according to a study published online recently in the American Journal of Psychiatry.

Patrick Quinn, Ph.D., of Indiana University Bloomington, and colleagues looked at data from 2,993,887 Americans with ADHD.

The researchers found that, compared to patients who did not take ADHD medications, the risk of alcohol or drug abuse was 35 percent lower among men and 31 percent lower among women who took medications such as amphetamine/dextroamphetamine, methylphenidate, and atomoxetine.

"While concerns about prescribing medications to treat ADHD that have the potential for abuse are understandable, this study provides further evidence that the use of these medications is not associated with increased risk of substance use problems in adolescence or adulthood," Quinn said in a university news release. "Rather, this and other recent studies find that the risk of such problems is lower during and after periods of use of these medications."

Abstract/Full Text (subscription or payment may be required)